Ogeda S.A.   Report issue

For profit Phase 2
Founded: Gosselies Belgium (1994)
Status: Acquired by Astellas (2017) → now Leo Pharma (2015)

Organization Overview

First Clinical Trial
2015
NCT05419908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ogeda SA | Ogeda S.A.

Active Ingredients

Drugs in Phase 2 Trials (1)

fezolinetant (Veozah) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hot Flashes (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1